STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLLS
  4. [EFFECT] Cellectis S.A. American SEC Filing

[EFFECT] Cellectis S.A. American SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: F-3
CIK: 0001627281
Company Name: Cellectis S.A.
File Number: 333-288491

Source: View Original Filing on SEC EDGAR

Cellectis

NASDAQ:CLLS

View CLLS Stock Overview →

CLLS Rankings

#3881 Ranked by Market Cap
N/A Ranked by Dividends

CLLS Latest News

Mar 19, 2026
Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update
Mar 12, 2026
Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
Mar 4, 2026
Monthly information on share capital and company voting rights
Feb 4, 2026
Monthly information on share capital and company voting rights
Jan 8, 2026
Cellectis Announces 2026 Strategy and Catalysts

CLLS Latest SEC Filings

Mar 19, 2026
[20-F] Cellectis S.A. Files Annual Report (Foreign Issuer)
Mar 19, 2026
[6-K] Cellectis S.A. Current Report (Foreign Issuer)
Mar 12, 2026
[6-K] Cellectis S.A. Current Report (Foreign Issuer)
Jan 8, 2026
[6-K] Cellectis S.A. Current Report (Foreign Issuer)
Dec 8, 2025
[6-K] Cellectis S.A. Current Report (Foreign Issuer)

CLLS Stock Data

338.99M
72.33M
Biotechnology
Healthcare
Link
France
Paris